Healthcare provider profile · identity verified

Gloria S Escobar, MD

Family Practice · ISLIP, NY · NPI 1992978654

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	373	111
Atorvastatin Calcium	Atorvastatin Calcium	361	121
Levothyroxine Sodium	Levothyroxine Sodium	348	102
Rosuvastatin Calcium	Rosuvastatin Calcium	262	84
Losartan Potassium	Losartan Potassium	246	81
Metformin Hcl	Metformin Hcl	220	66
Metoprolol Succinate	Metoprolol Succinate	208	70
Omeprazole	Omeprazole	183	61
Simvastatin	Simvastatin	173	55
Hydrochlorothiazide	Hydrochlorothiazide	171	52
Alendronate Sodium	Alendronate Sodium	152	47
Montelukast Sodium	Montelukast Sodium	144	58
Pantoprazole Sodium	Pantoprazole Sodium	135	38
Fluticasone Propionate	Fluticasone Propionate	111	45
Metformin Hcl Er	Metformin Hcl	105	30
Tamsulosin Hcl	Tamsulosin Hcl	104	36
Famotidine	Famotidine	103	49
Gabapentin	Gabapentin	98	46
Tizanidine Hcl	Tizanidine Hcl	98	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	30
Jardiance	Empagliflozin	89	24
Lisinopril	Lisinopril	87	28
Glipizide Er	Glipizide	77	20
Albuterol Sulfate Hfa	Albuterol Sulfate	76	34
Enalapril Maleate	Enalapril Maleate	68	21
Clopidogrel	Clopidogrel Bisulfate	66	24
Meloxicam	Meloxicam	65	24
Trazodone Hcl	Trazodone Hcl	64	26
Alprazolam	Alprazolam	63	25
Triamcinolone Acetonide	Triamcinolone Acetonide	63	46
Diclofenac Sodium	Diclofenac Sodium	62	33
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	59	15
Januvia	Sitagliptin Phosphate	55	14
Meclizine Hcl	Meclizine Hcl	54	24
Donepezil Hcl	Donepezil Hcl	53	17
Buspirone Hcl	Buspirone Hcl	51	15
Valsartan	Valsartan	50	17
Pravastatin Sodium	Pravastatin Sodium	49	18
Metoprolol Tartrate	Metoprolol Tartrate	48	20
Synthroid	Levothyroxine Sodium	48	14
Duloxetine Hcl	Duloxetine Hcl	46	14
Glipizide	Glipizide	45	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	31
Mupirocin	Mupirocin	41	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Carvedilol	Carvedilol	39	13
Dropsafe Prep Pads	Alcohol Antiseptic Pads	38	11
Allopurinol	Allopurinol	37	11
Labetalol Hcl	Labetalol Hcl	37	12
Furosemide	Furosemide	36	16
Atenolol	Atenolol	34	suppressed
Cromolyn Sodium	Cromolyn Sodium	34	16
Irbesartan	Irbesartan	33	suppressed
Nystatin	Nystatin	33	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Ibuprofen	Ibuprofen	31	11
Sertraline Hcl	Sertraline Hcl	30	14
Eliquis	Apixaban	29	13
Naproxen	Naproxen	29	17
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	11
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Azithromycin	Azithromycin	26	24
Ezetimibe	Ezetimibe	26	suppressed
Ozempic	Semaglutide	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Finasteride	Finasteride	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	18
Linzess	Linaclotide	24	suppressed
Ammonium Lactate	Ammonium Lactate	23	15
Lactulose	Lactulose	23	14
Ibandronate Sodium	Ibandronate Sodium	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Prednisone	Prednisone	17	15
Pregabalin	Pregabalin	17	suppressed
Ramipril	Ramipril	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Galantamine Er	Galantamine Hbr	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Dexilant	Dexlansoprazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Terconazole	Terconazole	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Torsemide	Torsemide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Budesonide Er	Budesonide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mesalamine Dr	Mesalamine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error